Stay updated on LGX818/MEK162 vs Vemurafenib/LGX818 in Melanoma Clinical Trial

Sign up to get notified when there's something new on the LGX818/MEK162 vs Vemurafenib/LGX818 in Melanoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the LGX818/MEK162 vs Vemurafenib/LGX818 in Melanoma Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    Added revision v3.5.0 and deleted revision v3.4.3 from the study record history.
    Difference
    0.1%
    Check dated 2026-03-19T04:44:50.000Z thumbnail image
  2. Check
    10 days ago
    Change Detected
    Summary
    Revision: v3.4.3 was added and Revision: v3.4.2 was removed on the history page.
    Difference
    0.1%
    Check dated 2026-03-11T23:00:59.000Z thumbnail image
  3. Check
    17 days ago
    Change Detected
    Summary
    New core study data sections were added to the record, including Adverse Events, Outcome Measures (Results), Baseline Characteristics, Participant Flow, Contacts/Locations, Study Status, and Study Identification. The history shows a new version entry (51).
    Difference
    0.6%
    Check dated 2026-03-04T23:26:18.000Z thumbnail image
  4. Check
    25 days ago
    No Change Detected
  5. Check
    39 days ago
    Change Detected
    Summary
    Revision: v3.4.2 was added to the history, and the funding-lapse notice and Revision: v3.4.1 were removed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-11T12:16:31.000Z thumbnail image
  6. Check
    46 days ago
    Change Detected
    Summary
    Added a government funding/status notice and a site revision update from v3.4.0 to v3.4.1.
    Difference
    0.4%
    Check dated 2026-02-04T06:53:34.000Z thumbnail image
  7. Check
    53 days ago
    Change Detected
    Summary
    Added the glossary display and color-coded change highlights on the history page, and introduced a new revision label (Revision: v3.4.0) while removing the older label (v3.3.4) and the 'No FEAR Act Data' text.
    Difference
    0.5%
    Check dated 2026-01-28T04:33:17.000Z thumbnail image

Stay in the know with updates to LGX818/MEK162 vs Vemurafenib/LGX818 in Melanoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the LGX818/MEK162 vs Vemurafenib/LGX818 in Melanoma Clinical Trial page.